Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05827614 |
|---|---|
| Brief Title: | Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications (POTENTIATE) |
| First Submitted : | March 27, 2023 |
| First Submitted that Met QC Criteria : | April 12, 2023 |
| First Posted : | April 25, 2023 |
| Last Update Submitted that Met QC Criteria : | February 27, 2024 |
| Last Update Posted : | February 28, 2024 |